{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:57:30Z","timestamp":1780631850154,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1007\/s11883-004-0029-2","type":"journal-article","created":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T23:52:33Z","timestamp":1179791553000},"page":"173-179","source":"Crossref","is-referenced-by-count":13,"title":["Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy"],"prefix":"10.1007","volume":"6","author":[{"given":"Rajagopal V.","family":"Sekhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farook","family":"Jahoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Pownall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Balasubramanyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"29_CR1","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Burton S, et al.: A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998, 12:F51-F58.","journal-title":"AIDS"},{"key":"29_CR2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(97)11443-X","volume":"351","author":"JC Lo","year":"1998","unstructured":"Lo JC, Mulligan K, Tai VW, et al.: \u201cBuffalo hump\u201d in men with HIV-1 infection. Lancet 1998, 351:867\u2013870.","journal-title":"Lancet"},{"key":"29_CR3","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/archinte.160.13.2050","volume":"160","author":"S Tsiodras","year":"2000","unstructured":"Tsiodras S, Mantzoros C, Hammer S, Samore M: Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study. Arch Intern Med 2000, 160:2050\u20132056.","journal-title":"Arch Intern Med"},{"key":"29_CR4","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","volume":"13","author":"T Saint-Marc","year":"1999","unstructured":"Saint-Marc T, Partisani M, Poizot-Martin I, et al.: A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy. AIDS 1999, 13:1659\u20131667.","journal-title":"AIDS"},{"key":"29_CR5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.189.1.51","volume":"189","author":"T Kino","year":"1999","unstructured":"Kino T, Gragerov A, Kopp JB, et al.: The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J Exp Med 1999, 189:51\u201362.","journal-title":"J Exp Med"},{"key":"29_CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1464-2662.2001.00100.x","volume":"3","author":"S Mauss","year":"2002","unstructured":"Mauss S, Corzillius M, Wolf E, et al.: Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment. HIV Med 2002, 3:49\u201355.","journal-title":"HIV Med"},{"key":"29_CR7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","volume":"361","author":"A Carr","year":"2003","unstructured":"Carr A, Emery S, Law M, et al.: An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 2003, 361:726\u2013735.","journal-title":"Lancet"},{"key":"29_CR8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","volume":"14","author":"T Saint-Marc","year":"2000","unstructured":"Saint-Marc T, Partisani M, Poizot-Martin I, et al.: Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS 2000, 14:37\u201349.","journal-title":"AIDS"},{"key":"29_CR9","first-page":"50","volume":"31","author":"E Bernasconi","year":"2002","unstructured":"Bernasconi E, Boubaker K, Junghans C, et al.: Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study. J AIDS 2002, 31:50\u201355.","journal-title":"J AIDS"},{"key":"29_CR10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-3542(00)00102-9","volume":"47","author":"JM Lenhard","year":"2000","unstructured":"Lenhard JM, Furfine ES, Jain RG, et al.: HIV protease inhibitors block adipogenesis and increase lipolysis in vitro. Antiviral Res 2000, 47:121\u2013129.","journal-title":"Antiviral Res"},{"key":"29_CR11","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/00002030-200208160-00003","volume":"16","author":"AR Miserez","year":"2002","unstructured":"Miserez AR, Muller PY, Spaniol V: Indinavir inhibits sterol-regulatory element-binding protein-1c-dependent lipoprotein lipase and fatty acid synthase gene activations. AIDS 2002, 16:1587\u20131594.","journal-title":"AIDS"},{"key":"29_CR12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/135965350100600301","volume":"6","author":"DJ Nolan","year":"2001","unstructured":"Nolan DJ, Mallal S: Antiretroviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis. Antiviral Ther 2001, 6:145\u2013160.","journal-title":"Antiviral Ther"},{"key":"29_CR13","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","volume":"15","author":"KA Lichtenstein","year":"2001","unstructured":"Lichtenstein KA, Ward DJ, Moorman AC, et al.: Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001, 15:1389\u20131398.","journal-title":"AIDS"},{"key":"29_CR14","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","volume":"100","author":"D Periard","year":"1999","unstructured":"Periard D, Telenti A, Sudre P, et al.: Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation 1999, 100:700\u2013705.","journal-title":"Circulation"},{"key":"29_CR15","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1097\/00002030-200009080-00008","volume":"14","author":"H Hatano","year":"2000","unstructured":"Hatano H, Miller KD, Yoder CP, et al.: Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy. AIDS 2000, 14:1935\u20131942.","journal-title":"AIDS"},{"key":"29_CR16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00002030-200105040-00005","volume":"15","author":"M Valk van der","year":"2001","unstructured":"van der Valk M, Gisolf EH, Reiss P, et al.: Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection. AIDS 2001, 15:847\u2013855.","journal-title":"AIDS"},{"key":"29_CR17","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","volume":"17","author":"N Friis-Moller","year":"2003","unstructured":"Friis-Moller N, Weber R, Reiss P, et al.: Cardiovascular disease risk factors in HIV patients\u2014association with antiretroviral therapy. Results from the DAD study. AIDS 2003, 17:1179\u20131193.","journal-title":"AIDS"},{"key":"29_CR18","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/00002030-200111090-00004","volume":"15","author":"M Valk van der","year":"2001","unstructured":"van der Valk M, Bisschop PH, Romijn JA, et al.: Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways. AIDS 2001, 15:2093\u20132100.","journal-title":"AIDS"},{"key":"29_CR19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00002030-200204120-00005","volume":"16","author":"H Murata","year":"2002","unstructured":"Murata H, Hruz PW, Mueckler M: Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations. AIDS 2002, 16:859\u2013863.","journal-title":"AIDS"},{"key":"29_CR20","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.2337\/diabetes.51.11.3163","volume":"51","author":"SK Gan","year":"2002","unstructured":"Gan SK, Samaras K, Thompson CH, et al.: Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. Diabetes 2002, 51:3163\u20133169.","journal-title":"Diabetes"},{"key":"29_CR21","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/00002030-200211080-00011","volume":"16","author":"J Sutinen","year":"2002","unstructured":"Sutinen J, Hakkinen AM, Westerbacka J, et al.: Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy. AIDS 2002, 16:2183\u20132193.","journal-title":"AIDS"},{"key":"29_CR22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","volume":"348","author":"SA Bozzette","year":"2003","unstructured":"Bozzette SA, Ake CF, Tam HK, et al.: Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003, 348:702\u2013710.","journal-title":"N Engl J Med"},{"key":"29_CR23","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","volume":"349","author":"N Friis-Moller","year":"2003","unstructured":"Friis-Moller N, Sabin CA, Weber R, et al.: Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003, 349:1993\u20132003.","journal-title":"N Engl J Med"},{"key":"29_CR24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/108729103321655863","volume":"17","author":"S Lai","year":"2003","unstructured":"Lai S, Lai H, Celentano DD, Vlahov D, et al.: Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors. AIDS Patient Care STDS 2003, 17:211\u2013219.","journal-title":"AIDS Patient Care STDS"},{"key":"29_CR25","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","volume":"17","author":"M Mary-Krause","year":"2003","unstructured":"Mary-Krause M, Cotte L, Simon A, et al.: Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 2003, 17:2479\u20132486.","journal-title":"AIDS"},{"key":"29_CR26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","volume":"360","author":"SD Holmberg","year":"2002","unstructured":"Holmberg SD, Moorman AC, Williamson JM, et al.: Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002, 360:1747\u20131748.","journal-title":"Lancet"},{"key":"29_CR27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ahj.2003.07.007","volume":"147","author":"P Varriale","year":"2004","unstructured":"Varriale P, Saravi G, Hernandez E, Carbon F: Acute myocardial infarction in patients infected with human immunodeficiency virus. Am Heart J 2004, 147:55\u201359.","journal-title":"Am Heart J"},{"key":"29_CR28","doi-asserted-by":"crossref","first-page":"E332","DOI":"10.1152\/ajpendo.00058.2002","volume":"283","author":"RV Sekhar","year":"2002","unstructured":"Sekhar RV, Jahoor F, White AC, et al.: Metabolic basis of HIV-lipodystrophy syndrome. Am J Physiol Endocrinol Metab 2002, 283:E332-E337.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"29_CR29","doi-asserted-by":"crossref","first-page":"E490","DOI":"10.1152\/ajpendo.00118.2003","volume":"285","author":"DN Reeds","year":"2003","unstructured":"Reeds DN, Mittendorfer B, Patterson BW, et al.: Alterations in lipid kinetics in men with HIV-dyslipidemia. Am J Physiol Endocrinol Metab 2003, 285:E490-E497.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"29_CR30","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1172\/JCI200215626","volume":"110","author":"GM Behrens","year":"2002","unstructured":"Behrens GM, Boerner AR, Weber K, et al.: Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy. J Clin Invest 2002, 110:1319\u20131327.","journal-title":"J Clin Invest"},{"key":"29_CR31","first-page":"291","volume":"20","author":"P Bjorntorp","year":"1996","unstructured":"Bjorntorp P: the regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996, 20:291\u2013302.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"29_CR32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2337\/diabetes.50.1.123","volume":"50","author":"RL Dobbins","year":"2001","unstructured":"Dobbins RL, Szczepaniak LS, Bentley B, et al.: Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 2001, 50:123\u2013130.","journal-title":"Diabetes"},{"key":"29_CR33","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/diabetes.48.6.1270","volume":"48","author":"ME Griffin","year":"1999","unstructured":"Griffin ME, Marcucci MJ, Cline GW, et al.: Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999, 48:1270\u20131274.","journal-title":"Diabetes"},{"key":"29_CR34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0005-2760(90)90291-5","volume":"1043","author":"UG Saxena","year":"1990","unstructured":"Saxena UG: Interaction of lipoportein lipase with glycosaminoglycans and apolipoprotein C-II: effects of free fatty acids. Biochim Biophys Acta 1990, 1043:161\u2013168.","journal-title":"Biochim Biophys Acta"},{"key":"29_CR35","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/01.ATV.12.11.1336","volume":"12","author":"J Patsch","year":"1992","unstructured":"Patsch J, Miesenbock G, Hopferwieser T, et al.: Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb Vasc Biol 1992, 12:1336\u20131345.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"29_CR36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0005-2760(90)90206-D","volume":"1045","author":"PJ Barter","year":"1990","unstructured":"Barter PJ, Chang LB, Newnham HH, et al.: The interaction of cholesteryl ester transfer protein and unesterified fatty acids promotes a reduction in the particle size of high-density lipoproteins. Biochim Biophys Acta 1990, 1045:81\u201389.","journal-title":"Biochim Biophys Acta"},{"key":"29_CR37","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.ATV.15.9.1388","volume":"15","author":"L Lagrost","year":"1995","unstructured":"Lagrost L, Florentin E, Guyard-Dangremont V, et al.: Evidence for nonesterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma. Arterioscler Thromb Vasc Biol 1995, 15:1388\u20131396.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"29_CR38","first-page":"H2","volume":"19","author":"J Patsch","year":"1998","unstructured":"Patsch J: Influence of lipolysis on chylomicron clearance and HDL cholesterol levels. Eur Heart J 1998, 19:H2-H6.","journal-title":"Eur Heart J"},{"key":"29_CR39","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg SP, McCann D, Desai M, et al.: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796\u20131808.","journal-title":"J Clin Invest"},{"key":"29_CR40","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","volume":"112","author":"H Xu","year":"2003","unstructured":"Xu H, Barnes GT, Yang Q, et al.: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821\u20131830.","journal-title":"J Clin Invest"},{"key":"29_CR41","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00002030-200307040-00011","volume":"17","author":"C Vigouroux","year":"2003","unstructured":"Vigouroux C, Maachi M, Nguyen TH, et al.: Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy. AIDS 2003, 17:1503\u20131511.","journal-title":"AIDS"},{"key":"29_CR42","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.1152\/ajpendo.00056.2003","volume":"286","author":"JA Johnson","year":"2004","unstructured":"Johnson JA, Albu JB, Engelson ES, et al.: Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy. Am J Physiol Endocrinol Metab 2004, 286:E261-E271.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"29_CR43","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/00002030-200308150-00004","volume":"17","author":"K Kannisto","year":"2003","unstructured":"Kannisto K, Sutinen J, Korsheninnikova E, et al.: Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy. AIDS 2003, 17:1753\u20131762.","journal-title":"AIDS"},{"key":"29_CR44","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","volume":"86","author":"C Weyer","year":"2001","unstructured":"Weyer C, Funahashi T, Tanaka S, et al.: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930\u20131935.","journal-title":"J Clin Endocrinol Metab"},{"key":"29_CR45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.ATV.0000048856.22331.50","volume":"23","author":"M Kumada","year":"2003","unstructured":"Kumada M, Kihara S, Sumitsuji S, et al.: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23:85\u201389.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"29_CR46","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1210\/jc.2002-021711","volume":"88","author":"R Weiss","year":"2003","unstructured":"Weiss R, Dufour S, Groszmann A, et al.: Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 2003, 88:2014\u20132018.","journal-title":"J Clin Endocrinol Metab"},{"key":"29_CR47","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/01.CIR.0000042707.50032.19","volume":"106","author":"Y Okamoto","year":"2002","unstructured":"Okamoto Y, Kihara S, Ouchi N, et al.: Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002, 106:2767\u20132770.","journal-title":"Circulation"},{"key":"29_CR48","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","volume":"7","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi T, Kamon J, Waki H, et al.: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941\u2013946.","journal-title":"Nat Med"},{"key":"29_CR49","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2002-020795","volume":"88","author":"CL Addy","year":"2003","unstructured":"Addy CL, Gavrila A, Tsiodras S, et al.: Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab 2003, 88:627\u2013636.","journal-title":"J Clin Endocrinol Metab"},{"key":"29_CR50","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1210\/jc.2002-021600","volume":"88","author":"Q Tong","year":"2003","unstructured":"Tong Q, Sankale JL, Hadigan CM, et al.: Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices. J Clin Endocrinol Metab 2003, 88:1559\u20131564.","journal-title":"J Clin Endocrinol Metab"},{"key":"29_CR51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/415339a","volume":"415","author":"Y Minokoshi","year":"2002","unstructured":"Minokoshi Y, Kim YB, Peroni OD, et al.: Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002, 415:339\u2013343.","journal-title":"Nature"},{"key":"29_CR52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.53.082901.104057","volume":"53","author":"R Unger","year":"2002","unstructured":"Unger R: Lipotoxic diseases. Annu Rev Med 2002, 53:319\u2013336.","journal-title":"Annu Rev Med"},{"key":"29_CR53","first-page":"564","volume":"33","author":"TM Riddle","year":"2003","unstructured":"Riddle TM, Fichtenbaum CJ, Hui DY: Leptin replacement therapy but not dietary polyunsaturated fatty acid alleviates HIV protease inhibitor-induced dyslipidemia and lipodystrophy in mice. J AIDS 2003, 33:564\u2013570.","journal-title":"J AIDS"},{"key":"29_CR54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0303-7207(01)00394-X","volume":"175","author":"CC Gerhardt","year":"2001","unstructured":"Gerhardt CC, Romero IA, Cancello R, et al.: Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001, 175:81\u201392.","journal-title":"Mol Cell Endocrinol"},{"key":"29_CR55","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/107602960200800211","volume":"8","author":"DA Hyson","year":"2002","unstructured":"Hyson DA, Paglieroni TG, Wun T, Rutledge JC: Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men. Clin Appl Thromb Hemost 2002, 8:147\u2013155.","journal-title":"Clin Appl Thromb Hemost"},{"key":"29_CR56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(97)09032-6","volume":"351","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Hennekens CH, Roitman-Johnson B, et al.: Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998, 351:88\u201392.","journal-title":"Lancet"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-004-0029-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-004-0029-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-004-0029-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T23:09:56Z","timestamp":1683846596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-004-0029-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1007\/s11883-004-0029-2","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}